| LifeCycle Pharma Moves LCP-Tacro™ into Clinical Phase 3 - Earthtimes (press release) |
|
|
The clinical trial protocol has been reviewed by FDA, and LCP expects to enroll approximately 300 stable kidney transplant patients in the program. ... |